Published in Gene Therapy Weekly, December 12th, 2002
Scientists have identified the tumor-associated antigen HER-2/neu in some gastric cancers. Previous studies have shown dendritic cells made to overexpress the oncogene HER-2/neu act as cancer antigens in tumor vaccines. Medical researchers are currently evaluating whether or not such vaccines would be effective for treating gastric cancer.
Koji Kono and colleagues, Yamanashi Medical University, Japan, collaborated with medical investigators at Karolinska Hospital in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.